日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune biomarker evaluation of sequential tyrosine kinase inhibitor and nivolumab monotherapies in renal cell carcinoma: the phase I TRIBE trial

肾细胞癌中酪氨酸激酶抑制剂和 nivolumab 单药治疗的免疫生物标志物评估:I 期 TRIBE 试验

K S Shohdy, M Pillai, K S Abbas, J Allison, T Waddell, E Darlington, S Mohammad, S Hood, S Atkinson, K Simpson, D Morgan, P Nathan, E Kilgour, C Dive, F Thistlethwaite

Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome

对癌症患者在 COVID-19 感染前后血液学和生化指标的纵向分析揭示了与预后相关的特征。

Lee, R J; Wysocki, O; Bhogal, T; Shotton, R; Tivey, A; Angelakas, A; Aung, T; Banfill, K; Baxter, M; Boyce, H; Brearton, G; Copson, E; Dickens, E; Eastlake, L; Gomes, F; Hague, C; Harrison, M; Horsley, L; Huddar, P; Hudson, Z; Khan, S; Khan, U T; Maynard, A; McKenzie, H; Palmer, D; Robinson, T; Rowe, M; Thomas, A; Tweedy, J; Sheehan, R; Stockdale, A; Weaver, J; Williams, S; Wilson, C; Zhou, C; Dive, C; Cooksley, T; Palmieri, C; Freitas, A; Armstrong, A C

Erratum to 'Longitudinal characterisation of haematological and biochemical parameters in cancer patients prior to and during COVID-19 reveals features associated with outcome': [ESMO Open Volume 6, Issue 1, February 2021, 100005]

对“COVID-19 之前和期间癌症患者的血液学和生化参数的纵向特征分析揭示了与预后相关的特征”的勘误:[ESMO Open 第 6 卷,第 1 期,2021 年 2 月,100005]

Lee, R J; Wysocki, O; Bhogal, T; Shotton, R; Tivey, A; Angelakas, A; Aung, T; Banfill, K; Baxter, M; Boyce, H; Brearton, G; Copson, E; Dickens, E; Eastlake, L; Gomes, F; Hague, C; Harrison, M; Horsley, L; Huddar, P; Hudson, Z; Khan, S; Khan, U T; Maynard, A; McKenzie, H; Palmer, D; Robinson, T; Rowe, M; Thomas, A; Tweedy, J; Sheehan, R; Stockdale, A; Weaver, J; Williams, S; Wilson, C; Zhou, C; Dive, C; Cooksley, T; Palmieri, C; Freitas, A; Armstrong, A C

Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial

循环肿瘤细胞在局限期小细胞肺癌中的预后价值:同步每日一次与每日两次放疗(CONVERT)随机对照试验分析

Tay, R Y; Fernández-Gutiérrez, F; Foy, V; Burns, K; Pierce, J; Morris, K; Priest, L; Tugwood, J; Ashcroft, L; Lindsay, C R; Faivre-Finn, C; Dive, C; Blackhall, F

Imaging biomarker roadmap for cancer studies

癌症研究的影像生物标志物路线图

O'Connor, James P B; Aboagye, Eric O; Adams, Judith E; Aerts, Hugo J W L; Barrington, Sally F; Beer, Ambros J; Boellaard, Ronald; Bohndiek, Sarah E; Brady, Michael; Brown, Gina; Buckley, David L; Chenevert, Thomas L; Clarke, Laurence P; Collette, Sandra; Cook, Gary J; deSouza, Nandita M; Dickson, John C; Dive, Caroline; Evelhoch, Jeffrey L; Faivre-Finn, Corinne; Gallagher, Ferdia A; Gilbert, Fiona J; Gillies, Robert J; Goh, Vicky; Griffiths, John R; Groves, Ashley M; Halligan, Steve; Harris, Adrian L; Hawkes, David J; Hoekstra, Otto S; Huang, Erich P; Hutton, Brian F; Jackson, Edward F; Jayson, Gordon C; Jones, Andrew; Koh, Dow-Mu; Lacombe, Denis; Lambin, Philippe; Lassau, Nathalie; Leach, Martin O; Lee, Ting-Yim; Leen, Edward L; Lewis, Jason S; Liu, Yan; Lythgoe, Mark F; Manoharan, Prakash; Maxwell, Ross J; Miles, Kenneth A; Morgan, Bruno; Morris, Steve; Ng, Tony; Padhani, Anwar R; Parker, Geoff J M; Partridge, Mike; Pathak, Arvind P; Peet, Andrew C; Punwani, Shonit; Reynolds, Andrew R; Robinson, Simon P; Shankar, Lalitha K; Sharma, Ricky A; Soloviev, Dmitry; Stroobants, Sigrid; Sullivan, Daniel C; Taylor, Stuart A; Tofts, Paul S; Tozer, Gillian M; van Herk, Marcel; Walker-Samuel, Simon; Wason, James; Williams, Kaye J; Workman, Paul; Yankeelov, Thomas E; Brindle, Kevin M; McShane, Lisa M; Jackson, Alan; Waterton, John C

Distinct subclonal tumour responses to therapy revealed by circulating cell-free DNA

循环游离 DNA 揭示亚克隆肿瘤对治疗的不同反应

G Gremel, R J Lee, M R Girotti, A K Mandal, S Valpione, G Garner, M Ayub, S Wood, D G Rothwell, A Fusi, A Wallace, G Brady, C Dive, N Dhomen, P Lorigan, R Marais

Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study

致瘤性非小细胞肺癌间充质循环肿瘤细胞:临床案例研究

C J Morrow, F Trapani, R L Metcalf, G Bertolini, C L Hodgkinson, G Khandelwal, P Kelly, M Galvin, L Carter, K L Simpson, S Williamson, C Wirth, N Simms, L Frankliln, K K Frese, D G Rothwell, D Nonaka, C J Miller, G Brady, F H Blackhall, C Dive

A caspase-3 'death-switch' in colorectal cancer cells for induced and synchronous tumor apoptosis in vitro and in vivo facilitates the development of minimally invasive cell death biomarkers

结肠直肠癌细胞中的 caspase-3“死亡开关”可在体内和体外诱导和同步肿瘤细胞凋亡,促进微创细胞死亡生物标志物的开发

K L Simpson, C Cawthorne, C Zhou, C L Hodgkinson, M J Walker, F Trapani, M Kadirvel, G Brown, M J Dawson, M MacFarlane, K J Williams, A D Whetton, C Dive

A selective matrix metalloproteinase-12 inhibitor retards atherosclerotic plaque development in apolipoprotein E-knockout mice

选择性基质金属蛋白酶-12抑制剂可延缓载脂蛋白E敲除小鼠动脉粥样硬化斑块的形成

Johnson, Jason L; Devel, Laurent; Czarny, Bertrand; George, Sarah J; Jackson, Christopher L; Rogakos, Vassilis; Beau, Fabrice; Yiotakis, Athanasios; Newby, Andrew C; Dive, Vincent

Issues on fit-for-purpose validation of a panel of ELISAs for application as biomarkers in clinical trials of anti-Angiogenic drugs

关于一组用于抗血管生成药物临床试验中作为生物标志物的ELISA检测方法的适用性验证问题

Brookes, K; Cummings, J; Backen, A; Greystoke, A; Ward, T; Jayson, G C; Dive, C